A MicroRNA Signature in Pediatric Ulcerative Colitis
Γεώργιος Κούκος(San Francisco VA Medical Center), Dimitrios Iliopoulos(Dana-Farber Cancer Institute), Jess L. Kaplan(Massachusetts General Hospital), Christos Polytarchou(Dana-Farber Cancer Institute), David Ziring(University of California, Los Angeles), Angelos Oikonomopoulos(Cardiovascular Institute of the South), Harland S. Winter(Massachusetts General Hospital), Daniël W. Hommes(InterScience (United States)), Renaisa Wahed(Beth Israel Deaconess Medical Center), Efi Kokkotou(Beth Israel Deaconess Medical Center), Charalabos Pothoulakis(Beth Israel Deaconess Medical Center)
Cited by 59
Related Papers
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
|PLoS ONE|2010|910